Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $45,689 | $26,218 | $24,253 | $21,194 |
Gross Profit | 25,221 | 1,650 | -1,039 | -7,449 |
EBITDA | -33,811 | -56,935 | -65,952 | -64,703 |
EBIT | -35,972 | -59,629 | -68,579 | -68,066 |
Net Income | -39,111 | -71,598 | -90,201 | -79,118 |
Net Change In Cash | 45,689 | 26,218 | 24,253 | 21,194 |
Free Cash Flow | -25,982 | -68,000 | -91,086 | -52,379 |
Cash | 171,414 | 130,925 | 104,132 | 86,124 |
Basic Shares | 266,158 | 266,143 | 266,143 | 266,141 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $75,564 | $10,120 | $1,698 | $6,194 |
Gross Profit | -21,030 | -130,900 | 1,698 | 6,194 |
EBITDA | -250,255 | -233,073 | -156,770 | -132,240 |
EBIT | -260,092 | -240,789 | -163,335 | -139,662 |
Net Income | -288,199 | -220,662 | -208,383 | -148,839 |
Net Change In Cash | 75,564 | 10,120 | 1,698 | 6,194 |
Free Cash Flow | -310,700 | -241,090 | -156,573 | -123,149 |
Cash | 104,132 | 227,380 | 239,566 | 382,436 |
Basic Shares | 266,138 | 255,161 | 173,941 | 94,993 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.15 |
2026-03-31 | -$0.27 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.30 |